NY Community (NYCB) Coveraged By UBS with $12.0000 Target; Profile of 4 Analysts Covering Immune Pharmaceuticals Inc. (IMNP)

Among 4 analysts covering Immune Pharma (NASDAQ:IMNP), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Immune Pharma had 4 analyst reports since October 8, 2015 according to SRatingsIntel. As per Thursday, October 8, the company rating was initiated by Roth Capital. The stock of Immune Pharmaceuticals Inc. (NASDAQ:IMNP) earned “Buy” rating by TH Capital on Thursday, October 8. The firm has “Buy” rating by Chardan Capital Markets given on Tuesday, October 13. See Immune Pharmaceuticals Inc. (NASDAQ:IMNP) latest ratings:

05/01/2018 Broker: Maxim Group Rating: Buy New Target: $3.0

Among 15 analysts covering New York Community Bancorp Inc. (NYSE:NYCB), 4 have Buy rating, 2 Sell and 9 Hold. Therefore 27% are positive. New York Community Bancorp Inc. has $19 highest and $11.0 lowest target. $14.65’s average target is 12.61% above currents $13.01 stock price. New York Community Bancorp Inc. had 40 analyst reports since August 20, 2015 according to SRatingsIntel. Piper Jaffray maintained the stock with “Sell” rating in Wednesday, January 31 report. The rating was maintained by FBR Capital with “Underperform” on Thursday, April 27. The rating was maintained by Keefe Bruyette & Woods on Friday, July 28 with “Hold”. The firm earned “Neutral” rating on Friday, October 7 by Wedbush. Piper Jaffray maintained the shares of NYCB in report on Tuesday, September 19 with “Sell” rating. Morgan Stanley maintained New York Community Bancorp, Inc. (NYSE:NYCB) rating on Thursday, February 1. Morgan Stanley has “Equal-Weight” rating and $14.75 target. On Wednesday, January 31 the stock rating was maintained by Sandler O’Neill with “Buy”. FBR Capital upgraded it to “Hold” rating and $13.0 target in Monday, February 12 report. On Tuesday, October 3 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. Sterne Agee CRT initiated New York Community Bancorp, Inc. (NYSE:NYCB) rating on Thursday, August 20. Sterne Agee CRT has “Neutral” rating and $18 target.

Analysts await New York Community Bancorp, Inc. (NYSE:NYCB) to report earnings on April, 25. They expect $0.20 EPS, down 4.76% or $0.01 from last year’s $0.21 per share. NYCB’s profit will be $98.05M for 16.26 P/E if the $0.20 EPS becomes a reality. After $0.17 actual EPS reported by New York Community Bancorp, Inc. for the previous quarter, Wall Street now forecasts 17.65% EPS growth.

New York Community Bancorp, Inc. operates as a holding firm for New York Community Bank and New York Commercial Bank that offer banking products and financial services in Metro New York, New Jersey, Ohio, Florida, and Arizona. The company has market cap of $6.38 billion. The firm offers various deposit products that include checking and savings accounts, individual retirement accounts, certificates of deposit, NOW and money market accounts, and non-interest-bearing accounts. It has a 14.47 P/E ratio. The Company’s loan portfolio comprises one-to-four family loans; multi-family loans; commercial real estate loans; acquisition, development, and construction loans; specialty finance loans and leases; and other C&I loans consist primarily of home equity loans and lines of credit, as well as various consumer loans.

The stock decreased 3.49% or $0.47 during the last trading session, reaching $13.01. About 5.12 million shares traded or 6.45% up from the average. New York Community Bancorp, Inc. (NYSE:NYCB) has declined 13.57% since March 25, 2017 and is downtrending. It has underperformed by 30.27% the S&P500.

Investors sentiment decreased to 0.99 in Q3 2017. Its down 0.05, from 1.04 in 2017Q2. It is negative, as 37 investors sold New York Community Bancorp, Inc. shares while 97 reduced holdings. 30 funds opened positions while 109 raised stakes. 278.63 million shares or 0.22% more from 278.04 million shares in 2017Q2 were reported. Great West Life Assurance Company Can invested 0.02% of its portfolio in New York Community Bancorp, Inc. (NYSE:NYCB). Rhumbline Advisers reported 0.03% stake. Hsbc Holdings Public Limited Liability Corp reported 0% in New York Community Bancorp, Inc. (NYSE:NYCB). Raymond James & Assocs stated it has 698,063 shares or 0.02% of all its holdings. Ngam Advisors L P holds 64,454 shares or 0.01% of its portfolio. 592,339 are owned by Credit Suisse Ag. Kistler reported 49,354 shares stake. Huntington Natl Bank reported 5,230 shares. Commonwealth Bank Of Australia holds 0.01% of its portfolio in New York Community Bancorp, Inc. (NYSE:NYCB) for 67,536 shares. Next Fincl Grp stated it has 2,849 shares or 0.01% of all its holdings. Pub Employees Retirement System Of Ohio stated it has 183,596 shares. Axa holds 0.02% or 430,600 shares. National Bank & Trust Of America De invested 0.01% in New York Community Bancorp, Inc. (NYSE:NYCB). Toronto Dominion Comml Bank holds 20,654 shares or 0% of its portfolio. California State Teachers Retirement Systems invested in 872,006 shares or 0.02% of the stock.

The stock decreased 2.30% or $0.008 during the last trading session, reaching $0.353. About 450,925 shares traded. Immune Pharmaceuticals Inc. (NASDAQ:IMNP) has declined 52.93% since March 25, 2017 and is downtrending. It has underperformed by 69.63% the S&P500.